Vaishali Pharma reports Profit after tax of Rs -14.49 Mln, in the March 2021 quarter

16 May 2021 Evaluate
The sales declined to Rs. 188.82 millions for the March 2021 quarter as compared to Rs. 211.45 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2021 is Rs. -14.49 millions as compared to Net Loss of Rs. -8.16 millions of corresponding quarter ended March 2020 Operating profit Margin for the quarter ended March 2021 further decreased to -7.87% as compared to -0.16% of corresponding quarter ended March 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202003 201903 % Var
Sales 188.82 211.45 -10.70 537.74 600.86 -10.50 600.86 750.91 -19.98
Other Income 5.73 13.68 -58.11 18.09 22.27 -18.77 21.73 19.82 9.64
PBIDT -7.87 -0.16 4818.75 44.41 30.52 45.51 29.98 40.40 -25.79
Interest 10.67 7.23 47.58 26.10 24.81 5.20 24.81 26.39 -5.99
PBDT -18.54 -7.39 150.88 18.31 5.71 220.67 5.17 14.01 -63.10
Depreciation 1.13 3.29 -65.65 4.27 5.12 -16.60 4.38 2.69 62.83
PBT -19.67 -10.68 84.18 14.04 0.59 2279.66 0.79 11.32 -93.02
TAX -5.18 -2.52 105.56 3.59 0.46 680.43 0.46 4.19 -89.02
Deferred Tax -0.20 -0.10 100.00 -0.20 -0.10 100.00 -0.10 -0.31 -67.74
PAT -14.49 -8.16 77.57 10.45 0.13 7938.46 0.33 7.13 -95.37
Equity 105.46 105.46 0.00 105.46 105.46 0.00 105.46 105.46 0.00
PBIDTM(%) -4.17 -0.08 5405.94 8.26 5.08 62.59 4.99 5.38 -7.26
Peers
Company Name CMP
Sun Pharma Inds. 826.70
Cipla 950.10
Dr. Reddy's Lab 4384.35
Aurobindo Pharma 522.55
Lupin 628.55
View more..